Scholars Central

Conference abstractPublished 14 Apr 2014

Weak points in clinical trials for aesthetic dermatology- How to improve?

Authors: Igor Rudenko

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Current situation in Aesthetic Dermatology needs more evidence-based data for proving safety of drug, devises and techniques. Unfortunately not all clinical trials are based on the principles of GCP and some of them contain bias. Clinical data that received in such trials cannot be use for building science and serves only as clinical experience with lowest rate of EBM. It were analyzed some clinical trials within aesthetic dermatology with revealing weak points and methods of its correction were proposed. Some clinical designs are demonstrated. We can organize clinical trials with sufficient evidence rate only with full understanding principles of GCP and methodology of bias avoiding.

Subjects

Dermatology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Dermatology Research
  • SubjectDermatology
  • BylineArticles whose byline prints “Igor Rudenko”